Vancomycin Dosing in Severe Renal Impairment (eGFR 9)
For a patient with an eGFR of 9 mL/min/1.73m², administer a full loading dose of 25-30 mg/kg (actual body weight) regardless of renal function, followed by maintenance doses of 250-1,000 mg every 7-10 days, with mandatory trough monitoring before each subsequent dose. 1, 2
Loading Dose Strategy
- The loading dose is NOT affected by renal function and must be given at full weight-based dosing (25-30 mg/kg actual body weight) to rapidly achieve therapeutic concentrations. 1, 3
- This loading dose applies even in severe renal dysfunction because it is designed to fill the volume of distribution, which remains unchanged regardless of kidney function. 1
- Infuse the loading dose over 2 hours (120 minutes) to minimize infusion-related reactions, and consider antihistamine premedication for large doses. 3, 2
- A fixed 1-gram loading dose is inadequate and will fail to achieve therapeutic levels in most patients, particularly those weighing >70 kg. 3
Maintenance Dosing in Severe Renal Impairment
- For patients with eGFR <10 mL/min (functionally anephric), the FDA label recommends maintenance doses of 250-1,000 mg every 7-10 days rather than daily administration. 2
- The specific maintenance dose required to maintain stable concentrations is approximately 1.9 mg/kg per 24 hours, but given the severe renal impairment, this translates to infrequent larger doses. 2
- With an eGFR of 9, the patient requires approximately 155 mg per 24 hours based on the dosing table, but practical administration involves giving 250-1,000 mg every 7-10 days. 2
Mandatory Therapeutic Monitoring
- Draw trough levels before EACH maintenance dose in patients with severe renal dysfunction, not just before the fourth dose as in patients with normal renal function. 3, 4
- Target trough concentrations of 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia). 1, 3, 4
- For non-severe infections, target trough levels of 10-15 mg/L. 3, 5
- Monitor serum creatinine at least twice weekly throughout therapy to detect further deterioration or improvement in renal function. 4
Critical Management Principles
- If trough levels exceed 20 mg/L, immediately hold the next scheduled dose and recheck the trough before administering any subsequent doses. 5, 4
- Once the trough decreases to the target range (15-20 mg/L for serious infections), resume vancomycin at a reduced dose or with an extended interval. 5
- The risk of nephrotoxicity increases significantly with trough levels >20 mg/L, especially with concurrent nephrotoxic agents. 3, 6
- Recent evidence suggests that loading doses do not increase nephrotoxicity compared to lower doses even in patients with severe renal dysfunction (eGFR <30). 7
Alternative Therapy Considerations
- If the vancomycin MIC is ≥2 μg/mL, switch to an alternative agent (daptomycin, linezolid, or ceftaroline) as target AUC/MIC ratios are not achievable with conventional dosing. 3, 4
- For MRSA pneumonia specifically, consider linezolid as first-line due to superior lung penetration and documented superior outcomes compared to vancomycin. 3
Common Pitfalls to Avoid
- Never reduce or omit the loading dose based on renal function—this is the most common error and leads to delayed achievement of therapeutic levels. 1, 3
- Do not use fixed 1-gram doses, as these result in subtherapeutic levels in most patients. 1, 3
- Avoid relying solely on eGFR in patients with low muscle mass (HIV, malnutrition, elderly), as creatinine-based estimates may significantly overestimate actual kidney function. 8
- Never continue the same maintenance dose when trough levels exceed 20 mg/L, as this dramatically increases nephrotoxicity risk. 5, 4
- Do not monitor peak levels—trough concentrations are the only validated monitoring method. 3, 4
Dialysis Considerations
- If the patient is on intermittent hemodialysis, administer a weight-based loading dose of 20-25 mg/kg, with maintenance dosing influenced by dialysis timing, filter type, and residual renal function. 9
- For patients requiring dialysis due to vancomycin toxicity, sustained trough concentrations >20 μg/mL combined with acute kidney injury (serum creatinine increase ≥0.5 mg/dL or 150% from baseline) warrant consideration for renal replacement therapy. 5